The Remote Monitoring of Gout Feasibility Study
NCT06211322 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2024-12-11
Summary
In this feasibility trial, a digital follow-up treatment strategy with patient self-management app (Urika) and remote monitoring in specialist healthcare for patients with gout will be tested.
Conditions
Interventions
- DEVICE
-
"Urika", a self-management application for patients with gout
The self-management software application (Urika) will include information videos on gout and treatment, reminders of daily medication and blood tests, a built-in algorithm for medical dosage escalation, visualization and log of serum urate levels, motivational gamification, asynchronous chat function patient-health professionals, and a platform for remote monitoring by health professionals.
Sponsors & Collaborators
-
Diakonhjemmet Hospital
lead OTHER
Principal Investigators
-
Nina Østerås, Prof. · Diakonhjemmet Hospital
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-27
- Primary Completion
- 2024-09-26
- Completion
- 2024-10-11
Countries
- Norway
Study Locations
More Related Trials
-
Virtual Gout Clinic
NCT02790463 ·Status: COMPLETED ·Phase: NA
-
Tight Control of Gouty Arthritis Compared to Usual Care
NCT05507723 ·Status: RECRUITING ·Phase: NA
-
Novel Methods for Ascertainment of Gout Flares -A Pilot Study
NCT02855437 ·Status: COMPLETED ·Phase: NA
-
Study of URC102 to Assess the Safety and Efficacy in Gout Patients
NCT02557126 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout
NCT00741442 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration
NCT05109936 ·Status: RECRUITING ·Phase: PHASE3
-
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT02290210 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
NCT01082640 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
NCT01510769 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
NCT01568879 ·Status: COMPLETED ·Phase: NA
-
Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life
NCT01549210 ·Status: COMPLETED
-
Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
NCT01109121 ·Status: COMPLETED ·Phase: PHASE2
-
Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT04804111 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
NCT06887452 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Gout Dose Response Study
NCT00955981 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
NCT06139393 ·Status: COMPLETED ·Phase: PHASE3
-
Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout
NCT06956885 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Nurse Led Patient Management Programme to Improve Outcomes in Gout
NCT03345186 ·Status: COMPLETED ·Phase: NA
-
UR+AIMS Gout Wearable Skin Uric Acid Monitor Study
NCT06187519 ·Status: COMPLETED ·Phase: NA
-
DECT Study in Allopurinol-Treated Gout Patients
NCT02393560 ·Status: COMPLETED
-
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
NCT06622603 ·Status: RECRUITING ·Phase: PHASE4
-
A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients
NCT05815901 ·Status: COMPLETED ·Phase: PHASE3
-
Urica Cor Intervention (URICORI) Trial
NCT04459936 ·Status: WITHDRAWN ·Phase: NA
-
Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit
NCT03162341 ·Status: COMPLETED ·Phase: NA
-
Treat-to-target by Email During Urate-lowering Therapy in Gout
NCT04733079 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA